Navigation Links
JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2013 FINANCIAL RESULTS
Date:5/7/2013

e, and adjust the income tax provision to the estimated amount of taxes that are payable in cash; (ii) the historical adjusted combined SG&A and R&D expenses exclude from GAAP combined SG&A and R&D expenses, as applicable, share-based compensation expense, transaction, integration and restructuring costs, depreciation, upfront license fees and change in fair value of contingent consideration; (iii) the adjusted net income guidance measures exclude from estimated GAAP net income amortization of intangible assets and depreciation, share-based compensation expense, acquisition accounting inventory fair value step-up adjustments, transaction, integration and restructuring costs, change in fair value of contingent consideration, upfront license fees and other non-cash expense, and adjust the income tax provision to the estimated amount of taxes that are payable in cash; (iv) the adjusted gross margin percentage guidance excludes from estimated GAAP gross margin percentage share-based compensation expense, acquisition accounting inventory fair value step-up adjustments and restructuring expense; and (v) the adjusted combined SG&A and R&D expenses guidance excludes from estimated GAAP combined SG&A and R&D expenses share-based compensation expense, transaction, integration and restructuring costs, depreciation, change in fair value of contingent consideration and upfront license fees.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995This press release contains forward-looking statements, including, but not limited to, statements related to Jazz Pharmaceuticals' future financial results and growth potential, including 2013 financial guidance, plans to pursue investment opportunities, future collaboration activities, potential share repurchases and other statements that are not historical facts. These forward-looking statements are based on Jazz Pharmaceuticals' current expectations and inherently invol
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock
2. Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy
3. Kinex Pharmaceuticals and Zenith Technology Corporation announce the execution of a collaborative licensing agreement
4. Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer
5. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
6. Valeant Pharmaceuticals Provides Efinconazole Update
7. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
8. Cumberland Pharmaceuticals Reports First Quarter Financial Results
9. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
10. Webcast Alert: Isis Pharmaceuticals First Quarter 2013 Financial Results Conference Call
11. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... BILLERICA, Mass. , June 2, 2015 /PRNewswire/ ... of Merck KGaA of Darmstadt, ... technology that compacts dry powder cell culture media ... handling. The compacted media are therefore more convenient ... their upstream processes. Photo - ...
(Date:6/2/2015)... GATOS, Calif. , June 2, 2015 ... you to shift mental states in minutes; feeling more calm ... for the first time, the sleek and simple wearable is ... home, work, or while commuting. The neurosignaling device is operated ... you achieve calm or increase your energy level. ...
(Date:6/2/2015)... MADRID , June 2, 2015 /PRNewswire/ ... meeting annuale della American Society of Clinical Oncology    ... multicentrico di fase 3 SAR3007, resi noti dal dipartimento ... hanno evidenziato un significativo miglioramento della sopravvivenza libera da ... ) rispetto al trattamento con dacarbazina in pazienti con ...
Breaking Medicine Technology:EMD Millipore Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production 2EMD Millipore Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production 3Thync Launches First Wearable to Shift Your State of Mind 2Thync Launches First Wearable to Shift Your State of Mind 3Thync Launches First Wearable to Shift Your State of Mind 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6
... Md., March 26, 2012 MedImmune announced today it ... Online (NIC Online), from March 26 – 28, 2012.  ... attendees will participate in live or archived sessions entirely ... on pediatric influenza vaccination and the safety and efficacy ...
... International, Inc., a leading global supplier of medical imaging ... is has contributed $5000 to the American Cancer Society ... Key Gala, that benefits the Boston Hope Lodge, and ... 29, 2012. "We are pleased to make ...
Cached Medicine Technology:MedImmune to Present Nine Abstracts Related to Influenza Vaccination at First Online National Immunization Conference 2Quest International Donates $5000 to the American Cancer Society 2
(Date:6/2/2015)... 2015 TU-Automotive Detroit is the biggest ... 150+ speakers include senior execs from GM, Chrysler, Mercedes, ... provide a crucial status update on the automotive technology ... just 24 hours to secure one of the remaining ... wait for tomorrow. There are 70 sessions looking across ...
(Date:6/2/2015)... The health care leaders who established ... value-based care will now offer health coverage for those ... The newly launched Crystal Run Health Plans has received ... Preferred Provider Organization (PPO) and Exclusive Provider Organization (EPO) ... and CEO, Hal Teitelbaum, MD, JD, MBA , ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Shimadzu ... LCMS-8060 triple quadrupole mass spectrometer. The newest model ... LCMS-8060 combines Shimadzu’s proprietary ultrafast technologies (UF technologies) ... results in outstanding data quality and higher throughput ... applications. , The LCMS-8060 features new technology, including ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Recent findings ... indicate that while there has been a reduction in ... tripled and waterpipe vapor (hookah) usage has doubled among ... Pediatrician Dr. Russell Gombosi believes the national trend is ... could take 15 to 20 years to fully determine ...
(Date:6/2/2015)... Calif. (PRWEB) June 02, 2015 ... and manufacturing high performance connector solutions and cable ... advanced connector solutions to the US market. , ... with Push-Pull locking capabilities. The self- securing circular ... of demanding applications that require significant customization such ...
Breaking Medicine News(10 mins):Health News:The Connected Car’s Biggest Event is Here – TU-Automotive Detroit 2015 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 3Health News:Shimadzu’s New LC-MS/MS Provides Superior Speed and Sensitivity for the Utmost in Quantitative Detection and High-Speed Analysis 2Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 2Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 3Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2
... injuries in people, doctors monitor blood level increases of ... the severity of the injury. Creatinine is filtered by ... early damage to vital kidney function. For pets suffering ... found that even tiny increases of creatinine in blood ...
... Dec. 19 (HealthDay News) -- Blood pressure changes in middle ... stroke, a new study suggests. U.S. researchers analyzed data ... for an average of 14 years. People who kept ... 55 had the lowest lifetime risk (22 percent to 41 ...
... MONDAY, Dec. 19 (HealthDay News) -- ,A new study finds ... one of the most aggressive forms of skin cancer. The ... Cutaneous melanoma is the fifth most commonly diagnosed cancer in ... U.S. women. Incidence of the cancer is increasing, and death ...
... Acupuncture significantly reduces levels of a protein in ... Medical Center (GUMC) have found. They say their animal ... many people receive from this ancient Chinese therapy., Published ... the researchers say that if their findings are ...
... molecules derived naturally in the body from a major ... acids [EETs]) are currently in clinical trials for the ... of researchers led by Dipak Panigrahy and Mark ... at the Institute for Systems Biology, Seattle; and Darryl ...
... called EETs currently under scrutiny as possible treatment targets ... the growth and spread of cancer, according to researchers at ... findings also raise the possibility that drugs that block EETs ... This study, led by Dipak Panigrahy, MD, of DF/CHCC and ...
Cached Medicine News:Health News:MU researchers find pet kidney injuries are similar to human kidney injuries 2Health News:Blood Pressure Control in Middle Age Can Lower Lifetime Heart Risk 2Health News:Previous Cancer May Up Melanoma Risk 2Health News:Acupuncture reduces protein linked to stress in first of its kind animal study 2Health News:Targeting EETs to treat cardiovascular disease may prove a double-edged sword 2Health News:Targeting EETs to treat cardiovascular disease may prove a double-edged sword 3
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 130 degrees....
Angled for easy insertion into side port incision for manipulation of nucleus. Flat, paddle like tip for placement in groove to crack the nucleus for emulsification....
Straight shaft with 0.2 mm hour glass shape tip. Round knurled handle with dull finish. Manufactured in titanium....
Flattened paddle tip with generous surface area is ideal for manipulating tissue, rotating and cracking the nucleus. Round knurled handle....
Medicine Products: